Carregant...

Smad4 loss promotes lung cancer formation but increases sensitivity to DNA topoisomerase inhibitors

Non-small cell lung cancer (NSCLC) is a common malignancy with a poor prognosis. Despite progress targeting oncogenic drivers, there are no therapies targeting tumor suppressor loss. Smad4 is an established tumor suppressor in pancreatic and colon cancer, however, the consequences of Smad4 loss in l...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncogene
Autors principals: Haeger, Sarah M., Thompson, Joshua J., Kalra, Sean, Cleaver, Timothy G., Merrick, Daniel, Wang, Xiao-Jing, Malkoski, Stephen P.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4615192/
https://ncbi.nlm.nih.gov/pubmed/25893305
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2015.112
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!